NovoCure Limited Diluted Shares Outstanding (Weighted Average)
NovoCure Limited (NVCR) reported Diluted Shares Outstanding (Weighted Average) of 116.01 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-07-23
- NovoCure Limited weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 116.01M shares, a 3.98% increase year-over-year.
- NovoCure Limited weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 114.15M shares, a 3.51% increase year-over-year.
- NovoCure Limited weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 112.11M shares, a 3.52% increase year-over-year.
- NovoCure Limited weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 111.91M shares, a 3.38% increase year-over-year.
- NovoCure Limited weighted average number of shares outstanding, diluted for fiscal 2024 was 107.83M shares, a 1.36% increase from fiscal 2023.
- NovoCure Limited weighted average number of shares outstanding, diluted for fiscal 2023 was 106.39M shares, a 1.65% increase from fiscal 2022.
- NovoCure Limited weighted average number of shares outstanding, diluted for fiscal 2022 was 104.66M shares, a 1.19% increase from fiscal 2021.
- NovoCure Limited weighted average number of shares outstanding, diluted for fiscal 2021 was 103.43M shares, a 5.00% decline from fiscal 2020.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 116.01M shares 10-Q · filed 2026-07-23 | 115.11M shares 10-Q · filed 2026-07-23 | 114.09M shares derived: average of 3 quarters · filed 2026-07-23 | 113.54M shares derived: average of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | 114.15M shares 10-Q · filed 2026-04-30 | 113.13M shares derived: average of 2 quarters · filed 2026-07-23 | 112.72M shares derived: average of 3 quarters · filed 2026-07-23 | 112.43M shares derived: average of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | 112.11M shares derived: 10-Q 12 month − 10-Q 9 month · filed 2026-07-23 | 112.01M shares derived: average of 2 quarters · filed 2026-07-23 | 111.86M shares derived: average of 3 quarters · filed 2026-07-23 | 111.47M shares 10-Q · filed 2026-07-23 |
| 2025-09-30 | 111.91M shares 10-Q · filed 2025-10-30 | 111.74M shares derived: average of 2 quarters · filed 2026-07-23 | 111.26M shares 10-Q · filed 2025-10-30 | 110.52M shares derived: average of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | 111.57M shares 10-Q · filed 2026-07-23 | 110.93M shares 10-Q · filed 2026-07-23 | 110.05M shares derived: average of 3 quarters · filed 2026-07-23 | 109.60M shares derived: average of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | 110.28M shares 10-Q · filed 2026-04-30 | 109.29M shares derived: average of 2 quarters · filed 2026-04-30 | 108.94M shares derived: average of 3 quarters · filed 2026-04-30 | 108.63M shares derived: average of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | 108.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 108.27M shares derived: average of 2 quarters · filed 2026-02-26 | 108.08M shares derived: average of 3 quarters · filed 2026-02-26 | 107.83M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 108.25M shares 10-Q · filed 2025-10-30 | 107.97M shares derived: average of 2 quarters · filed 2025-10-30 | 107.68M shares 10-Q · filed 2025-10-30 | 107.53M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 107.70M shares 10-Q · filed 2025-07-24 | 107.48M shares 10-Q · filed 2025-07-24 | 107.29M shares derived: average of 3 quarters · filed 2026-02-26 | 107.16M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 107.27M shares 10-Q · filed 2025-04-24 | 107.09M shares derived: average of 2 quarters · filed 2026-02-26 | 106.98M shares derived: average of 3 quarters · filed 2026-02-26 | 106.81M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 106.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 106.84M shares derived: average of 2 quarters · filed 2026-02-26 | 106.66M shares derived: average of 3 quarters · filed 2026-02-26 | 106.39M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 106.77M shares 10-Q · filed 2024-10-30 | 106.53M shares derived: average of 2 quarters · filed 2024-10-30 | 106.22M shares 10-Q · filed 2024-10-30 | 105.94M shares derived: average of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | 106.29M shares 10-Q · filed 2024-07-25 | 105.98M shares 10-Q · filed 2024-07-25 | 105.66M shares derived: average of 3 quarters · filed 2024-07-25 | 105.47M shares derived: average of 4 quarters · filed 2024-07-25 |
| 2023-03-31 | 105.67M shares 10-Q · filed 2024-05-02 | 105.35M shares derived: average of 2 quarters · filed 2024-05-02 | 105.19M shares derived: average of 3 quarters · filed 2024-05-02 | 105.05M shares derived: average of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | 105.03M shares 10-K · filed 2023-02-23 | 104.96M shares derived: average of 2 quarters · filed 2023-10-26 | 104.85M shares derived: average of 3 quarters · filed 2023-10-26 | 104.66M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 104.88M shares 10-Q · filed 2023-10-26 | 104.76M shares derived: average of 2 quarters · filed 2023-10-26 | 104.55M shares 10-Q · filed 2023-10-26 | 104.40M shares derived: average of 4 quarters · filed 2023-10-26 |
| 2022-06-30 | 104.63M shares 10-Q · filed 2023-07-27 | 104.41M shares 10-Q · filed 2023-07-27 | 104.23M shares derived: average of 3 quarters · filed 2023-07-27 | 104.11M shares derived: average of 4 quarters · filed 2023-07-27 |
| 2022-03-31 | 104.19M shares 10-Q · filed 2023-05-04 | 104.04M shares derived: average of 2 quarters · filed 2023-05-04 | 103.93M shares derived: average of 3 quarters · filed 2023-05-04 | 103.82M shares derived: average of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | 103.88M shares 10-K · filed 2023-02-23 | 103.81M shares derived: average of 2 quarters · filed 2023-02-23 | 103.70M shares derived: average of 3 quarters · filed 2023-02-23 | 103.43M shares 10-K · filed 2024-02-22 |
| 2021-09-30 | 103.73M shares 10-K · filed 2023-02-23 | 103.61M shares derived: average of 2 quarters · filed 2023-02-23 | 103.28M shares 10-Q · filed 2022-10-27 | 105.11M shares derived: average of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | 103.48M shares 10-K · filed 2023-02-23 | 103.06M shares 10-Q · filed 2022-07-28 | 105.57M shares derived: average of 3 quarters · filed 2023-02-23 | 106.34M shares derived: average of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | 102.63M shares 10-K · filed 2023-02-23 | 106.62M shares derived: average of 2 quarters · filed 2023-02-23 | 107.29M shares derived: average of 3 quarters · filed 2023-02-23 | 107.38M shares derived: average of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | 110.60M shares 10-K · filed 2023-02-23 | 109.62M shares derived: average of 2 quarters · filed 2023-02-23 | 108.97M shares derived: average of 3 quarters · filed 2023-02-23 | 108.88M shares 10-K · filed 2023-02-23 |
| 2020-09-30 | 108.64M shares 10-K · filed 2023-02-23 | 108.15M shares derived: average of 2 quarters · filed 2023-02-23 | 108.11M shares 10-Q · filed 2021-10-28 | 108.08M shares derived: average of 4 quarters · filed 2023-02-23 |
| 2020-06-30 | 107.65M shares 10-K · filed 2023-02-23 | 107.90M shares 10-Q · filed 2021-07-29 | 107.89M shares derived: average of 3 quarters · filed 2023-02-23 | 107.82M shares derived: average of 4 quarters · filed 2023-02-23 |
| 2020-03-31 | 108.10M shares 10-K · filed 2023-02-23 | 108.01M shares derived: average of 2 quarters · filed 2023-02-23 | 107.87M shares derived: average of 3 quarters · filed 2023-02-23 | 104.99M shares derived: average of 4 quarters · filed 2023-02-23 |
| 2019-12-31 | 107.91M shares 10-K · filed 2022-02-24 | 107.76M shares derived: average of 2 quarters · filed 2022-02-24 | 103.96M shares derived: average of 3 quarters · filed 2022-02-24 | 97.24M shares 10-K · filed 2022-02-24 |
| 2019-09-30 | 107.60M shares 10-K · filed 2022-02-24 | 101.98M shares derived: average of 2 quarters · filed 2022-02-24 | 96.55M shares 10-Q · filed 2020-10-29 | 97.96M shares derived: average of 4 quarters · filed 2022-02-24 |
| 2019-06-30 | 96.36M shares 10-K · filed 2022-02-24 | 95.58M shares 10-Q/A · filed 2020-10-02 | 94.75M shares derived: average of 3 quarters · filed 2022-02-24 | 94.29M shares derived: average of 4 quarters · filed 2022-02-24 |
| 2019-03-31 | 94.81M shares 10-K · filed 2022-02-24 | 93.95M shares derived: average of 2 quarters · filed 2022-02-24 | 93.60M shares derived: average of 3 quarters · filed 2022-02-24 | |
| 2018-12-31 | 93.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 93.00M shares derived: average of 2 quarters · filed 2021-02-25 | 91.83M shares 10-K · filed 2021-02-25 | |
| 2018-09-30 | 92.91M shares 10-Q · filed 2019-10-31 | 91.41M shares 10-Q · filed 2019-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |